Catalyst Wire Dossier Catalyst Wire Dossier

NTX-001

· Neuraptive Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NTX-001, covering 2024-11-20 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations. [Phase 3]

See pricing